Recon: FDA investigates iPhone-pacemaker interference; Humacyte's $245M SPAC deal
ReconKari Oakes
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyReconKari OakesBiologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesPharmaceuticalsRegulatory Intelligence/Policy